All filters
Abstracts
Evaluation of Second Line Antiretroviral Programmatic and Treatment Outcomes in Mozambique between 2015-2017
A. Muteerwa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
"You are not benefiting us by keeping us away": Why do some eligible people on antiretroviral therapy (ART) decline to participate in Ethiopia's appointment spacing model with 6-month ART dispensing?
J. Mantell
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Minimal cross-resistance to tenofovir in children and adolescents failing abacavir-based ART makes them eligible for tenofovir-lamivudine-dolutegravir treatment.
K. Steegen
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Factors associated with unsuppressed viral load among patients enrolled in the Community HIV Care Program in Botswana. A retrospective cross-sectional study.
C. Trapence
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving retention in ART care using Call-2Care© approach: A snapshot from Defence Forces of Zambia (DFZ)
P. Makelele
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The effect of home-based care in achieving viral load coverage in two high volume facilities in Akwa Ibom state, Nigeria
O. Toyo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving linkage to antiretroviral therapy using a peer attachment model in selected facilities in the Southern Highland Zone of Tanzania
A. Ngwalle
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Acceptability of Quadrimune, a new Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed dose combination
V. Musiime
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Limited increase in primary HIV‐1C drug resistance mutations in treatment naïve individuals in Ethiopia
K. Ghezehegn
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Comparative study on the liver profile of HIV positive pregnant women and HIV positive non-pregnant women attending the Bamenda Regional Hospital, Cameroon
M. Alice Enekegbe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Virological suppression among HIV infected adolescents and youths receiving ART in the National teaching and referral hospital in Kenya.
J. Kangethe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
HIV-1C proviral DNA for detection of drug resistance mutations
K. Ghezehegn
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Durability of Second-line Anti-Retroviral Therapy and Predictors of a Viral Rebound Among HIV Patients on Second-line ART in an HIV Specialist Clinic in Uganda: A 10-Year Retrospective Cohort
I. Lumu
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Zimbabwe’s National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment Outcomes
C. Chimbetete
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Low Baseline-Resistance to Integrase Inhibitors in Cameroon: Implications in the Era of Dolutegravir-based Regimens in Sub-Saharan Africa
E. Ngoufack Jagni Semengue
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
In Urban settings, Vertically-Infected Adolescents Experience Treatment Failure driven by HIV Drug Resistance Emergence: Results from a Follow-up Analysis in Cameroon
D. Njume
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Where are the men in Gaza? A cross-sectional study to understand the residency patterns of male partners of women accessing HIV services in Gaza, Mozambique
S. Ndima
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Accurate HIV Viral Load in Primary Healthcare Centers using Plasma Separation Cards
A. Vubil
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Burnett Plasma Separation device as alternative for HIV Viral Load Determination
A. Vubil
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Acquired drug resistance patterns and implications of use of tenofovir-lamivudine-dolutegravir (TLD) as second- or third-line regimens: evidence from real life experience in Cameroon
M.D.C. Collins Ambe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Using analysis of Viral Load Result for Targeted Index Testing (using 3rd 90 to achieve 1st 90)
M. Owusu
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Prevalence and factors associated with delayed antiretroviral therapy switching at rural public health facilities in Kiboga district, Uganda.
J. Nakakande
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving viral load suppression rates among HIV positive children on ART in a large volume HIV clinic in Western Uganda.
W. Akobye
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
“One size does not fit all” – views by stakeholders, men on ART and men in communities on improving men’s access to and continued engagement in ART in Malawi
A. Berner-Rodoreda
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020